Détention brevets de la classe A61K 38/18

Brevets de cette classe: 5934

Historique des publications depuis 10 ans

505
509
519
455
430
478
336
358
304
87
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
The Regents of the University of California
20556
123
Regeneron Pharmaceuticals, Inc.
4608
82
Acceleron Pharma Inc.
342
77
Amgen Inc.
4353
61
Warsaw Orthopedic, Inc.
2816
60
The Board of Trustees of the Leland Stanford Junior University
6592
59
Novartis AG
10345
56
University of Pittsburgh - Of the Commonwealth System of Higher Education
3263
55
President and Fellows of Harvard College
6044
53
NGM Biopharmaceuticals, Inc.
171
49
Translate bio, Inc.
413
47
Modernatx, Inc.
1280
45
Dompé Farmaceutici S.p.A.
294
41
New York University
1825
41
The Trustees of the University of Pennsylvania
4406
38
The General Hospital Corporation
4824
36
The Salk Institute for Biological Studies
452
33
Zensun (Shanghai) Science & Technology, Co., Ltd.
56
32
The Brigham and Women's Hospital, Inc.
2264
29
Merck Patent GmbH
5663
27
Autres propriétaires 4890